Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-08-22

Clinical Trial Update: Evaluation of SP Resistance and Effectiveness of IPTp in Nigeria [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update from Malaria Consortium evaluating resistance to sulfadoxine-pyrimethamine and the effectiveness of intermittent preventive trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Malaria Consortium, UK | Conditions: Pregnancy Complications Parasitic | Phase 4 | Status: UNKNOWN